SHY vs XBI
iShares 1-3 Year Treasury Bond ETF vs SPDR S&P Biotech ETF
SHY$81.93
iShares 1-3 Year Treasury Bond ETF
Short-term US Treasuries (1-3 years).
Expense: 0.15%Yield: 3.68%
XBI$164.01
SPDR S&P Biotech ETF
Equal-weight biotech stocks in the S&P Biotech Index.
Expense: 0.35%Yield: 0.36%
Quick take
- • SHY has the lower expense ratio at 0.15% vs 0.35% for XBI.
- • SHY pays a higher dividend yield (3.68%).
Side-by-side metrics
| Metric | SHY | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.15% | 0.35% |
Dividend yield Trailing 12-month yield. | 3.68% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $25.36B | $10.73B |
YTD return | 0.56% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.22 | 1.10 |
P/E ratio | 3,724.09 | — |
Last price | $81.93 | $164.01 |
Inception | — | — |
Issuer | iShares | State Street |
SHY top holdings
Holdings data unavailable for SHY.
XBI top holdings
Top holdings · XBI
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
Sector breakdown · XBI
Financial Services0.5%
Healthcare99.5%
About SHY
SHY (iShares 1-3 Year Treasury Bond ETF) is Short-term US Treasuries (1-3 years). Managed by iShares, the fund carries $25.4B in assets under management, an expense ratio of 0.15%, a dividend yield of 3.68%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.